A Prospective, Randomized, Double-Blind, Placebo-Controlled Multicenter Trial Comparing Early (7 Day) Corticosteroid Cessation Versus Long-Term, Low-Dose Corticosteroid Therapy-Reference-Cited by-同舟云学术

A Prospective, Randomized, Double-Blind, Placebo-Controlled Multicenter Trial Comparing Early (7 Day) Corticosteroid Cessation Versus Long-Term, Low-Dose Corticosteroid Therapy

Published:2008-10 Issue:4 Volume:248 Page:564-577
ISSN:0003-4932
Container-title:Annals of Surgery
language:en
Short-container-title:

Author:

Woodle E Steve,First M Roy,Pirsch John,Shihab Fuad,Gaber A Osama,Van Veldhuisen Paul

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Surgery

Reference27 articles.

1. The role of adrenocortical steroids in reversing established homograft rejection.;Marchioro;Surgery,1964

2. FK506 “rescue” for resistant rejection of renal allografts under primary cyclosporine immunosuppression.;Jordan;Transplantation,1994

3. Tacrolimus therapy for refractory renal allograft rejection: experience with steroid withdrawal.;Cronin;Transplant Proc,1997

4. Corticosteroid cessation 1 week following renal transplantation using tacrolimus/mycophenolate mofetil-based immunosuppression.;Grewal;Transplant Proc,1998

5. Immunosuppression: evolution in practice and trends 1994–2004.;Meier-Kriesche;Am J Transplant,2006

Cited by 379 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Immunosuppression in Kidney Transplant Recipients: An Update for the General Nephrologist;Advances in Kidney Disease and Health;2024-09

2. Immunosuppressive drug combinations after kidney transplantation and post-transplant diabetes: A systematic review and meta-analysis;Transplantation Reviews;2024-07

3. An update review of post‐transplant diabetes mellitus: Concept, risk factors, clinical implications and management;Diabetes, Obesity and Metabolism;2024-04

4. New-Onset Diabetes Mellitus after Kidney Transplantation;Journal of Clinical Medicine;2024-03-27

5. Outcomes of older Black renal transplant recipients receiving basiliximab induction and early steroid withdrawal;Clinical Transplantation;2024-02